Broker Recommendations Tenaya Therapeutics, Inc.

Stocks

TNYA

US87990A1060

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-16 pm EDT			5-day change	1st Jan Change
0.8376 ^USD	-0.66%		-1.46%	+17.72%

Jun. 29	Tenaya Therapeutics, Inc. Announces Management Changes, Effective July 13, 2026	CI
Jun. 29	Tenaya Therapeutics, Inc. Announces Chief Financial Officer Changes, Effective July 13, 2026	CI

Broker Recommendations

25-03-12	Chardan Adjusts Price Target on Tenaya Therapeutics to $9 From $18, Keeps Buy Rating	MT
24-12-17	Leerink Partners Adjusts Tenaya Therapeutics Price Target to $6 From $8, Maintains Outperform Rating	MT
24-06-10	William Blair Starts Tenaya Therapeutics With Outperform Rating	MT
24-05-16	Canaccord Genuity Adjusts Tenaya Therapeutics Price Target to $16 From $18, Maintains Buy Rating	MT
24-03-20	Canaccord Genuity Adjusts Price Target on Tenaya Therapeutics to $18 From $19, Maintains Buy Rating	MT
23-08-11	Canaccord Genuity Adjusts Price Target on Tenaya Therapeutics to $17 From $18, Keeps Buy Rating	MT
23-08-10	Morgan Stanley Adjusts Price Target on Tenaya Therapeutics to $14 From $13, Keeps Overweight Rating	MT
23-05-12	Chardan Trims Price Target on Tenaya Therapeutics to $23 From $24, Maintains Buy Rating	MT
23-03-09	HC Wainwright Adjusts Price Target on Tenaya Therapeutics to $18 From $25, Maintains Buy Rating	MT
23-03-09	Chardan Cuts Price Target on Tenaya Therapeutics to $24 From $28, Keeps Buy Rating	MT
23-01-24	Morgan Stanley Adjusts Price Target on Tenaya Therapeutics to $13 From $15, Maintains Overweight Rating	MT
22-11-11	Chardan Trims Price Target on Tenaya Therapeutics to $28 From $30, Affirms Buy Rating	MT
22-11-08	Canaccord Genuity Starts Tenaya Therapeutics at Buy With $21 Price Target	MT
22-08-11	Chardan Research Trims Tenaya Therapeutics' Price Target to $30 From $31, Maintains Buy Rating	MT
22-06-15	HC Wainwright Starts Tenaya Therapeutics at Buy With $25 Price Target	MT
22-05-17	Morgan Stanley Lowers Tenaya Therapeutics' Price Target to $15 From $19, Maintains Overweight Rating	MT
22-02-01	Morgan Stanley Adjusts Tenaya Therapeutics' Price Target to $19 from $31, Keeps Overweight Rating	MT
21-08-24	TENAYA THERAPEUTICS : Chardan Starts Tenaya Therapeutics at Buy with $37 Price Target on Heart Disease Drugs' Potential	MT
21-08-24	TENAYA THERAPEUTICS : Cowen Starts Tenaya Therapeutics at Outperform	MT
21-08-24	TENAYA THERAPEUTICS : Morgan Stanley Initiates Coverage on Tenaya Therapeutics With Overweight Rating, $31 Price Target	MT
21-08-24	TENAYA THERAPEUTICS : Piper Sandler Starts Tenaya Therapeutics at Overweight With $40 Price Target	MT